| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Mar 11, 2023 | Mar 14, 2023 | Iterum Therapeutics plc | CFO | Sell | 90.0 | +3,783 | 86.93% | ✗ | $2.8K |
| Mar 14, 2022 | Mar 15, 2022 | Iterum Therapeutics plc | CFO | Sell | 46.3 | -63,340 | -49.24% | ✗ | $19.6K |
| Mar 11, 2022 | Mar 15, 2022 | Iterum Therapeutics plc | CFO | Sell | 91.3 | +52,868 | 184.65% | ✗ | $17.9K |
| Jan 25, 2021 | Jan 27, 2021 | Iterum Therapeutics plc | CFO | Sell | 95.0 | +28,632 | 100.00% | ✗ | $58.6K |
| Sep 30, 2020 | Oct 2, 2020 | Iterum Therapeutics plc | CFO | Sell | 10.0 | -56,130 | -100.00% | ✓ | $92.1K |
| May 30, 2018 | May 30, 2018 | Iterum Therapeutics plc | CFO | Buy | 90.0 | +4,000 | 7.67% | ✗ | $52K |